China Medical System Holdings Limited (CMS) is an investment holding company. The Company operates in two segments: Marketing, promotion and sale of pharmaceutical products, which includes marketing, promotion and sale of in-licensed medicine and pharmaceutical products from overseas and domestic pharmaceutical companies to wholesale customers across China, including distributors and hospitals, and Other business, which include production and sales of other medicines and pharmaceutical products to wholesale customers across China, including distributors and hospitals and production and sales of medical instruments. Its products include Deanxit, XinHuoSu, Cystistat, Ursofalk, Nesiritide, Augentropfen Stulln Mono eye-drops, GanFuLe and Salofalk. During the year ended December 31, 2010, the Company introduced two new products, Bioflor and Exacin. In April 2010, the Company acquired additional 40% interest in Sky United Trading Limited (Sky United).